Pharmacovigilance Posts | JPCC Associates

top of page

Contact@JPCCAssociates.com

JPCC ASSOCIATES

PV Consulting by PV Professionals

Search

Crisis Prevention in Pharmacovigilance

Crisis Prevention in Pharmacovigilance

Crisis Prevention in Pharmacovigilance

Jean-Pierre (JP) Clement

Oct 12, 20165 min read

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

Jean-Pierre (JP) Clement

Oct 3, 20163 min read

The Expanding Role of PV in Pre-marketing Activities

The Expanding Role of PV in Pre-marketing Activities

The Expanding Role of PV in Pre-marketing Activities

Jean-Pierre (JP) Clement

Sep 7, 20163 min read

What do Pharmacovigilance and Market Research Programs have in common?

What do Pharmacovigilance and Market Research Programs have in common?

What do Pharmacovigilance and Market Research Programs have in common?

Jean-Pierre (JP) Clement

Sep 2, 20164 min read

Compliance Metrics for Pharmacovigilance Activities

Compliance Metrics for Pharmacovigilance Activities

Compliance Metrics for Pharmacovigilance Activities

Jean-Pierre (JP) Clement

Aug 19, 20163 min read

The Changing Competencies of Pharmacovigilance Leadership

The Changing Competencies of Pharmacovigilance Leadership

The Changing Competencies of Pharmacovigilance Leadership

Jean-Pierre (JP) Clement

Jun 27, 20164 min read

Did you just say Safety Governance Model?

Did you just say Safety Governance Model?

Did you just say Safety Governance Model?

Jean-Pierre (JP) Clement

May 27, 20163 min read

Practical aspects of the “new” IND Rule

Practical aspects of the “new” IND Rule

Practical aspects of the “new” IND Rule

Jean-Pierre (JP) Clement

May 23, 20164 min read

bottom of page